Myles Pensak, MD, to Head Otolaryngology Department
Myles Pensak, MD, has been named chairman of the Department of OtolaryngologyHead and Neck Surgery at the UC College of Medicine.
A professor in both the otolaryngology and neurosurgery departments at UC, Dr. Pensak has been on the College of Medicine faculty since 1984. He is a fellow of the American College of Surgeons and was recently honored with the Distinguished Service Award of the American Academy of OtolaryngologyHead and Neck Surgery, one of the oldest medical associations in the nation.
Were happy to have Dr. Pensak, who was trained at Yale and is internationally known as a researcher/surgeon with a focus in complex skull-based surgery, as chairman of otolaryngology, says Ronald Sacher, MD, interim dean of the College of Medicine.
Dr. Pensak succeeds Jack Gluckman, MD, who has headed the department since 1991 and has been a member of the UC College of Medicine faculty since 1977.
Many physicians in UCs otolaryngology department have been listed in Best Doctors in America, Best Doctors in the Midwest and Good Housekeeping magazines Best Doctors guide. The department has also been named one of the top 20 in the country by U.S. News & World Report magazine 10 times since 1993.
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.